Moreover, immunohistochemical detection showed that miR-183-5p antagomir reduced α-SMA expression in BDL-induced liver fibrosis when compared with the control antagomir group (Figures 2I,J). The gene discussed is ACTA1; the disease is Hepatic fibrosis.